Data Collective Discloses 8.1M Evolv Shares, 1.58M Sold in Aug 2025

Rhea-AI Filing Summary

Data Collective IV, L.P. ("DC IV") and related reporting persons report beneficial ownership of 8,096,335 shares of Evolv Technologies Holdings, Inc. Class A Common Stock, representing 4.7% of the 171,891,467 shares outstanding used to calculate the percentage. The shares held by DC IV resulted from prior preferred-stock and convertible-note investments in Old Evolv that converted into issuer common stock in connection with the business combination described in the filing.

The filing discloses multiple open-market sales by DC IV, including sales on August 11–18, 2025 totaling 1,584,946 shares for aggregate reported proceeds of approximately $12,357,398.50. The reporting persons state the securities are held for general investment purposes and that they may buy or sell depending on market and other conditions. The filing also references the Registration Rights Agreement that governs resale and lock-up arrangements following the business combination.

Positive

• Clear ownership disclosure: Reporting persons disclose they beneficially own 8,096,335 shares (4.7%) of Class A common stock.
• Provenance of holdings explained: Holdings resulted from multiple preferred-stock purchases and a convertible promissory note that converted at the business combination.
• Registration rights referenced: The filing cites the Amended and Restated Registration Rights Agreement governing resale and lock-up provisions.

Negative

• Substantial recent sales disclosed: DC IV sold 1,584,946 shares on August 11–18, 2025 for approximately $12,357,398.50 in reported proceeds.
• Falling below 5% threshold: The reporting persons "ceased to be beneficial owners of more than five percent" as of August 14, 2025, which may reduce their influence.

Insights

Financial Analyst

TL;DR: Reporting persons hold 8,096,335 shares (4.7%) and completed sizable recent open-market sales totaling 1.58M shares.

The filing documents the origin of the stake in Evolv from multiple preferred purchases and a $3.0M convertible note that converted into common stock at the business combination. The reported 4.7% position is clearly quantified against 171,891,467 outstanding Class A shares. Recent sales from August 11–18, 2025 account for 1,584,946 shares and roughly $12.36 million in proceeds, all disclosed with per‑trade price ranges. The reporting persons maintain the position for general investment purposes and reserve the right to increase or decrease holdings based on market and other conditions. For investors, the filing provides clear ownership, provenance of shares, and liquidity actions by a significant pre‑combination holder.

Corporate Governance Expert

TL;DR: The filing shows institutional investor DC IV reduced its stake while noting registration rights and lock-up history tied to the merger.

The document reiterates that the shares originated from preferred and convertible‑note conversions at the time of the business combination and references the Amended and Restated Registration Rights Agreement that governs resale mechanics and lock‑up periods. The reporting persons expressly disclaim beneficial ownership beyond pecuniary interest except as stated, and they disclose joint filing arrangements. The cessation of being a >5% beneficial owner as of August 14, 2025 is stated, which is a governance‑relevant threshold disclosure. The filing is procedurally complete and aligns with typical post‑SPAC/combination disclosure practices.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)

Evolv Technologies Holdings, Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

30049H102

(CUSIP Number)

Ryan Ward
270 University Avenue,
Palo Alto, CA, 94301
(415) 840-7337

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/14/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 30049H102

1

Name of reporting person

Data Collective IV, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,096,335.00
8	Shared Voting Power 8,096,335.00
9	Sole Dispositive Power 8,096,335.00
10	Shared Dispositive Power 8,096,335.00

11

Aggregate amount beneficially owned by each reporting person

8,096,335.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.7 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

Comment to 7: 8,096,335 shares, except that Data Collective IV GP, LLC ("DC IV GP"), the general partner of Data Collective IV, L.P. ("DC IV"), may be deemed to have sole power to vote these shares, and Matthew Ocko ("Ocko") and Zachary Bogue ("Bogue"), the managing members of DC IV GP, may be deemed to have shared power to vote these shares. Comment to 9: 8,096,335 shares, except that DC IV GP, the general partner of DC IV, may be deemed to have sole power to dispose of these shares, and Ocko and Bogue, the managing members of DC IV GP, may be deemed to have sole power to dispose of these shares. Comment to 13: The percentage is calculated based upon 171,891,467 shares of Class A Common Stock outstanding of Evolv Technologies Holdings, Inc. (the "Issuer"), as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 14, 2025.

SCHEDULE 13D

CUSIP No. 30049H102

1

Name of reporting person

Data Collective IV GP, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,096,335.00
8	Shared Voting Power 8,096,335.00
9	Sole Dispositive Power 8,096,335.00
10	Shared Dispositive Power 8,096,335.00

11

Aggregate amount beneficially owned by each reporting person

8,096,335.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.7 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

Comment to 7: 8,096,335 shares, all of which are directly owned by Data Collective IV, L.P. ("DC IV"). Data Collective IV GP, LLC ("DC IV GP"), the general partner of DC IV, may be deemed to have sole power to vote these shares, and Matthew Ocko ("Ocko") and Zachary Bogue ("Bogue"), the managing members of DC IV GP, may be deemed to have shared power to vote these shares. Comment to 9: 8,096,335 shares, all of which are directly owned by DC IV. DC IV GP, the general partner of DC IV, may be deemed to have sole power to dispose of these shares, and Ocko and Bogue, the managing members of DC IV GP, may be deemed to have shared power to dispose of these shares. Comment to 13: The percentage is calculated based upon 171,891,467 shares of Class A Common Stock outstanding of Evolv Technologies Holdings, Inc. (the "Issuer"), as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 14, 2025.

SCHEDULE 13D

CUSIP No. 30049H102

1

Name of reporting person

Matthew Ocko

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,096,335.00
8	Shared Voting Power 8,096,335.00
9	Sole Dispositive Power 8,096,335.00
10	Shared Dispositive Power 8,096,335.00

11

Aggregate amount beneficially owned by each reporting person

8,096,335.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.7 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Comment to 8: 8,096,335 shares, all of which are directly owned by Data Collective IV, L.P. ("DC IV"). Matthew Ocko ("Ocko") is a managing member of Data Collective IV GP, LLC ("DC IV GP"), which is the general partner of DC IV. Ocko may be deemed to have shared power to vote these shares. Comment to 10: 8,096,335 shares, all of which are directly owned by DC IV. Ocko is a managing member of DC IV GP, which is the general partner of DC IV. Ocko may be deemed to have shared power to dispose of these shares. Comment to 13: The percentage is calculated based upon 171,891,467 shares of Class A Common Stock outstanding of Evolv Technologies Holdings, Inc. (the "Issuer"), as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 14, 2025.

SCHEDULE 13D

CUSIP No. 30049H102

1

Name of reporting person

Zachary Bogue

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 8,096,335.00
8	Shared Voting Power 8,096,335.00
9	Sole Dispositive Power 8,096,335.00
10	Shared Dispositive Power 8,096,335.00

11

Aggregate amount beneficially owned by each reporting person

8,096,335.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.7 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Comment to 8: 8,096,335 shares, all of which are directly owned by Data Collective IV, L.P. ("DC IV"). Zachary Bogue ("Bogue") is a managing member of Data Collective IV GP, LLC ("DC IV GP"), which is the general partner of DC IV. Bogue may be deemed to have shared power to vote these shares. Comment to 10: 8,096,335 shares, all of which are directly owned by DC IV. Bogue is a managing member of DC IV GP, which is the general partner of DC IV. Bogue may be deemed to have shared power to dispose of these shares. Comment to 13: The percentage is calculated based upon 171,891,467 shares of Class A Common Stock outstanding of Evolv Technologies Holdings, Inc. (the "Issuer"), as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 14, 2025.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Class A Common Stock
(b)	Name of Issuer: Evolv Technologies Holdings, Inc.
(c)	Address of Issuer's Principal Executive Offices: 500 Totten Pond Road, 4th Floor, Waltham, MASSACHUSETTS , 02451.
Item 2.	Identity and Background
(a)	This Statement is being filed by Data Collective IV, L.P. ("DC IV"), Data Collective IV GP, LLC ("DC IV GP"), Matthew Ocko ("Ocko") and Zachary Bogue ("Bogue"). The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached hereto as Exhibit 1. Each of Ocko and Bogue is a managing member of DC IV GP and may be deemed to share voting, investment and dispositive power with respect to the securities held by DC IV. Each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein, if any, other than those securities reported herein as being held directly by such Reporting Person.
(b)	The address of the principal place of business for each of the Reporting Persons is c/o DCVC Management Co, LLC, 270 University Avenue, Palo Alto, CA 94301.
(c)	The principal occupation of each of the Reporting Persons is the venture capital investment business. The principal business of DC IV is to make investments in private and public companies. The principal business of DC IV GP is to serve as the general partner of DC IV. Ocko and Bogue are the managing members of each of DC IV GP.
(d)	During the last five years, none of the Reporting Persons has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	DC IV is a Delaware limited partnership. DC IV GP is a Delaware limited liability company. Ocko and Bogue are U.S. citizens.
Item 3.	Source and Amount of Funds or Other Consideration
	On November 14, 2016, DC IV purchased 14,326,647 shares of Evolv Technologies, Inc., a Delaware corporation ("Old Evolv"), Series A-1 preferred stock for a purchase price of approximately $0.28 per share and an aggregate purchase price of $3,999,999.84. On July 10, 2018, DC IV purchased 7,118,451 shares of Old Evolv Series B preferred stock for a purchase price of approximately $0.35 per share and an aggregate purchase price of $2,499,999.99. On June 3, 2019, DC IV purchased 1,809,373 shares of Old Evolv Series B-1 preferred stock for a purchase price of approximately $0.31 per share and an aggregate purchase price of $561,810.62. On September 13, 2019, DC IV purchased 587,270 shares of Old Evolv Series B-1 preferred stock for a purchase price of approximately $0.31 per share and an aggregate purchase price of $182,347.59. On October 16, 2019, DC IV purchased 2,920,238 shares of Old Evolv Series B-1 preferred stock for a purchase price of approximately $0.37 per share and an aggregate purchase price of $1,066,762.95. On January 1, 2021, Old Evolv issued a convertible promissory note to DC IV in the principal amount of $3,000,000.00. The "Business Combination" consisted of the merger of NHIC Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of NHIC ("Merger Sub"), with and into Old Evolv, with Old Evolv surviving the merger as a wholly owned subsidiary of HEC pursuant to the terms of the Agreement and Plan of Merger, dated as of March 5, 2021, as amended on June 5, 2021 (the "Merger Agreement"), by and among NHIC, Old Evolv and Merger Sub. The above summary is qualified by reference to such description and the full text of the Merger Agreement, which is filed as Exhibits 2 and 3 to this Statement and is incorporated herein by reference. On July 16, 2021 (the "Closing Date"), as a result of and upon the consummation of the Business Combination, each share of each series of Old Evolv's preferred stock was cancelled or assumed, as applicable and converted into the right to receive, at the election of the holders thereof, a number of shares of the Issuer's Common Stock, as adjusted pursuant to the Merger Agreement. The share numbers and prices reported above are reflected on a pre-conversion basis. On August 16, 2023, DC IV sold 19,423 shares of Common Stock at a weighted average price of approximately $7.57 per share, or $147,079.07 in the aggregate, in open market sales. The shares were sold at prices ranging from $7.50 to $7.715. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 21, 2023, DC IV sold 73,737 shares of Common Stock at a weighted average price of approximately $6.58 per share, or $485,413.81 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.51 to $6.705. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 22, 2023, DC IV sold 152,303 shares of Common Stock at a weighted average price of approximately $6.54 per share, or $996,345.86 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.50 to $6.655. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 23, 2023, DC IV sold 130,948 shares of Common Stock at a weighted average price of approximately $6.50 per share, or $851,357.81 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.50 to $6.55. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 24, 2023, DC IV sold 70,253 shares of Common Stock at a weighted average price of approximately $6.56 per share, or $460,754.97 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.50 to $6.60. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 29, 2023, DC IV sold 143,143 shares of Common Stock at a weighted average price of approximately $6.56 per share, or $939,105.50 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.50 to $6.6714. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 30, 2023, DC IV sold 10,193 shares of Common Stock at a weighted average price of approximately $6.50 per share, or $66,254.55 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.50 to $6.505. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 31, 2023, DC IV sold 200,000 shares of Common Stock at a weighted average price of approximately $6.77 per share, or $1,353,651.65 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.59 to $6.8772. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On September 1, 2023, DC IV sold 120,000 shares of Common Stock at a weighted average price of approximately $6.96 per share, or $834,753.34 in the aggregate, in open market sales. The shares were sold at prices ranging from $6.87 to $7.0136. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 11, 2025, DC IV sold 130,523 shares of Common Stock at a weighted average price of approximately $7.31 per share, or $954,616.57 in the aggregate, in open market sales. The shares were sold at prices ranging from $7.30 to $7.38. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 12, 2025, DC IV sold 171,198 shares of Common Stock at a weighted average price of approximately $7.42 per share, or $1,269,491.72 in the aggregate, in open market sales. The shares were sold at prices ranging from $7.30 to $7.515. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 13, 2025, DC IV sold 379,560 shares of Common Stock at a weighted average price of approximately $7.41 per share, or $2,813,163.98 in the aggregate, in open market sales. The shares were sold at prices ranging from $7.265 to $7.5252. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 15, 2025, DC IV sold 98,242 shares of Common Stock at a weighted average price of approximately $8.18 per share, or $804,012.53 in the aggregate, in open market sales. The shares were sold at prices ranging from $8.005 to $8.535. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. On August 18, 2025, DC IV sold 805,423 shares of Common Stock at a weighted average price of approximately $8.09 per share, or $6,516,113.70 in the aggregate, in open market sales. The shares were sold at prices ranging from $8.000 to $8.255. DC IV undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the previous sentence. The source of the funds for all purchases and acquisitions by DC IV was from working capital. No part of the purchase price was borrowed by DC IV for the purpose of acquiring any securities discussed in this Item 3.
Item 4.	Purpose of Transaction
	Pursuant to the terms of the Merger Agreement, DC IV's (i) 14,326,647 shares of Old Evolv's Series A-1 Preferred Stock, (ii) 7,118,451 shares of Old Evolv's Series B Preferred Stock, (iii) 5,316,881 shares of Old Evolv's Series B-1 Preferred Stock and (iv) a convertible promissory note in the principal amount of $3,000,000.00 converted into 10,601,281 shares, in the aggregate, of the Issuer's Common Stock. Subject to the Registration Rights Agreement (as defined in Item 6 below), the Reporting Persons hold the securities of the Issuer for general investment purposes. The Reporting Persons may, from time to time, depending on prevailing market, economic and other conditions, acquire additional shares of Common Stock or other securities of the Issuer, dispose of any such securities, or engage in discussions with the Issuer concerning such acquisitions or dispositions or further investments in the Issuer. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and, depending upon the price and availability of shares of Common Stock or other securities of the Issuer, subsequent developments affecting the Issuer, the Issuer's business and prospects, other investment and business opportunities available to the Reporting Persons, general stock market and economic conditions, tax considerations and other factors considered relevant, may decide at any time to increase or to decrease the size of their investment in the Issuer in the open market, in privately negotiated transactions. Except as set forth above, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	See Items 7-11 and Item 13 of the cover pages of this Statement and Item 2 above.
(b)	See Items 7-11 and Item 13 of the cover pages of this Statement and Item 2 above.
(c)	Except as set forth in Item 3 above, the Reporting Persons have not effected any transaction in the securities of the Issuer during the past 60 days.
(d)	Under certain circumstances set forth in the limited partnership agreement of DC IV and the limited liability company agreement of DC IV GP, the partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from the sale of, shares of the Issuer directly or indirectly owned by each such entity of which they are a partner or member.
(e)	The Reporting Persons ceased to be beneficial owners of more than five percent of the Issuer's securities as of August 14, 2025.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	On July 16, 2021, in connection with the consummation of the Business Combination and as contemplated by the Merger Agreement, the Issuer, NewHold Industrial Technology Holdings LLC, a Delaware limited liability company (the "Sponsor"), certain stockholders of NHIC and certain former stockholders of Old Evolv, including DC IV (the "Old Evolv Holders"), entered into the Amended and Restated Registration Rights Agreement (the "Registration Rights Agreement") pursuant to which the Issuer agreed to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of the Issuer's common stock and other equity securities. that are held by the parties thereto from time to time. The Registration Rights Agreement provides for, among other things, registration rights, including, among other things, customary demand, shelf and piggy-back rights, subject to certain restrictions, and customary cut-back provisions with respect to the shares of the Issuer's common stock or warrants to purchase shares of the Issuer's common stock held by the Old Evolv Holders following the Closing. In connection with the execution of the Registration Rights Agreement, certain stockholders of Old Evolv, including DC IV, agreed to be bound by the transfers restrictions on its lock-up shares during the period of 180 days after the Closing Date, in each case, subject to limited exceptions. The terms and provisions of the Registration Rights Agreement are described more fully in the Issuer's Form 8-K as filed with the SEC on July 22, 2021 (File No. 001-39417), and the above summary is qualified by reference to such description and the full text of the Registration Rights Agreement, which is filed as Exhibit 4 to this Statement and is incorporated herein by reference.
Item 7.	Material to be Filed as Exhibits.
	EXHIBIT 1 Agreement of Joint Filing. EXHIBIT 2 Agreement and Plan of Merger, dated as of March 5, 2021, by and among NHIC, the Merger Sub and Old Evolv (filed as Exhibit 2.1 to the Issuer's Form 8-K as filed with the SEC on July 22, 2021 (File No. 001-39417) and incorporated herein by reference). EXHIBIT 3 First Amendment to Agreement and Plan of Merger, dated as of June 5, 2021, by and among NHIC, the Merger Sub and Old Evolv (filed as Exhibit 2.2 to the Issuer's Form 8-K as filed with the SEC on July 22, 2021 (File No. 001-39417) and incorporated herein by reference). EXHIBIT 4 Amended and Restated Registration Rights Agreement, dated July 16, 2021, by and among the Issuer, the Sponsor and the Old Evolv Holders (filed as Exhibit 10.2 to the Issuer's Form 8-K as filed with the SEC on July 22, 2021 (File No. 001-39417) and incorporated herein by reference).

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Data Collective IV, L.P.

Signature:	/s/ Matthew Ocko
Name/Title:	Data Collective IV GP, LLC/General Partner Matthew Ocko/Managing Member
Date:	08/21/2025

Data Collective IV GP, LLC

Signature:	/s/ Matthew Ocko
Name/Title:	Matthew Ocko/Managing Member
Date:	08/21/2025

Matthew Ocko

Signature:	/s/ Matthew Ocko
Name/Title:	Matthew Ocko
Date:	08/21/2025

Zachary Bogue

Signature:	/s/ Zachary Bogue
Name/Title:	Zachary Bogue
Date:	08/21/2025

FAQ

How many Evolv (EVLV) Class A shares does Data Collective IV beneficially own?

The reporting persons beneficially own 8,096,335 shares of Class A common stock, equal to 4.7% of 171,891,467 shares outstanding as stated in the filing.

What is the origin of DC IV's stake in Evolv (EVLV)?

DC IV's position arose from multiple purchases of Old Evolv preferred stock between 2016–2019 and a $3,000,000 convertible promissory note, which converted into common stock in the business combination.

Did DC IV sell shares recently and how many?

Yes. The filing reports open‑market sales on several dates, including 1,584,946 shares sold between August 11 and August 18, 2025, with detailed per‑trade price ranges and aggregate proceeds reported.

Are there resale restrictions or registration rights affecting these shares?

Yes. The filing references the Amended and Restated Registration Rights Agreement dated July 16, 2021, which provides demand, shelf and piggy‑back registration rights and described lock‑up restrictions following the closing of the business combination.

What is the stated purpose for holding the shares?

The reporting persons state the securities are held for general investment purposes and that they may buy or sell shares depending on market, issuer developments and other factors.